Literature DB >> 21252630

Incidence of and risk factors for community acquired pneumonia in US HIV-infected children, 2000-2005.

Andrew P Steenhoff1, Joshua S Josephs, Richard M Rutstein, Kelly A Gebo, George K Siberry, Aditya H Gaur, Robert Warford, P Todd Korthuis, Stephen A Spector, Samir S Shah.   

Abstract

The incidence of and risk factors for community-acquired pneumonia (CAP) are described from 2000 to 2005 in a multicenter US cohort of HIV-infected children. In 736 patients, 87 episodes of CAP (33.2 events/1000 person-years) had a mean CD4% of 23% (controls: 30%) and mean CD4 cell count of 668 cells/μl (controls: 870 cells/μl). CAP incidence decreased 44% from 2000-2001 to 2002-2005. On multivariate analysis, viral load at least 100 000 copies/ml (odds ratio 3.98; confidence interval 1.05-15.13) was associated with CAP. Herd immunity through pneumococcal immunization may have diluted the effect of individual immunization in this cohort.

Entities:  

Mesh：

Year:  2011        PMID： 21252630      PMCID： PMC3576877          DOI： 10.1097/QAD.0b013e3283440583

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


  15 in total

1.  Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.

Authors:  Walter T Hughes; Wayne M Dankner; Ram Yogev; Sharon Huang; Mary E Paul; Midnela Acevedo Flores; Mark W Kline; Lee-Jen Wei
Journal:  Clin Infect Dis       Date:  2004-12-06       Impact factor: 9.079

2.  Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine.

Authors:  Richard I Haddy; Kelvin Perry; Chris E Chacko; William B Helton; Mark G Bowling; Stephen W Looney; George E Buck
Journal:  Pediatr Infect Dis J       Date:  2005-04       Impact factor: 2.129

3.  Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.

Authors:  Carrie L Byington; Matthew H Samore; Gregory J Stoddard; Steve Barlow; Judy Daly; Kent Korgenski; Sean Firth; David Glover; Jasmin Jensen; Edward O Mason; Cheryl K Shutt; Andrew T Pavia
Journal:  Clin Infect Dis       Date:  2005-05-26       Impact factor: 9.079

4.  Effect of trimethoprim-sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis on bacterial illness, Pneumocystis carinii pneumonia, and death in persons with AIDS.

Authors:  S E Buskin; L M Newcomer; L A Koutsky; T M Hooton; D H Spach; S G Hopkins
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1999-02-01

5.  Impact of the conjugate pneumococcal vaccine in arkansas.

Authors:  Gordon E Schutze; Nancy C Tucker; Edward O Mason
Journal:  Pediatr Infect Dis J       Date:  2004-12       Impact factor: 2.129

6.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

Authors:  Cynthia G Whitney; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James H Jorgensen; Anne Schuchat
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

7.  Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente.

Authors:  Steven Black; Henry Shinefield; Roger Baxter; Robert Austrian; Laura Bracken; John Hansen; Edwin Lewis; Bruce Fireman
Journal:  Pediatr Infect Dis J       Date:  2004-06       Impact factor: 2.129

8.  The impact of HIV on Streptococcus pneumoniae bacteraemia in a South African population.

Authors:  N Jones; R Huebner; M Khoosal; H Crewe-Brown; K Klugman
Journal:  AIDS       Date:  1998-11-12       Impact factor: 4.177

9.  Characteristics of acute pneumonia in human immunodeficiency virus-infected children and association with long term mortality risk. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.

Authors:  L M Mofenson; R Yogev; J Korelitz; J Bethel; K Krasinski; J Moye; R Nugent; J G Rigau-Perez
Journal:  Pediatr Infect Dis J       Date:  1998-10       Impact factor: 2.129

10.  Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia.

Authors:  Steven B Black; Henry R Shinefield; Stella Ling; John Hansen; Bruce Fireman; David Spring; Jack Noyes; Edwin Lewis; Paula Ray; Janelle Lee; Jill Hackell
Journal:  Pediatr Infect Dis J       Date:  2002-09       Impact factor: 2.129
View more
  9 in total

1.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

2.  Diagnosis and management of community-acquired pneumonia in children: South African Thoracic Society guidelines.

Authors:  H J Zar; D P Moore; S Andronikou; A C Argent; T Avenant; C Cohen; R J Green; G Itzikowitz; P Jeena; R Masekela; M P Nicol; A Pillay; G Reubenson; S A Madhi
Journal:  Afr J Thorac Crit Care Med       Date:  2020-10-13

Review 3.  Pathogenesis of HIV and the lung.

Authors:  Matthew R Gingo; Alison Morris
Journal:  Curr HIV/AIDS Rep       Date:  2013-03       Impact factor: 5.071

4.  Global, regional, and national estimates of pneumonia burden in HIV-infected children in 2010: a meta-analysis and modelling study.

Authors:  Evropi Theodoratou; David A McAllister; Craig Reed; Davies O Adeloye; Igor Rudan; Lulu M Muhe; Shabir A Madhi; Harry Campbell; Harish Nair
Journal:  Lancet Infect Dis       Date:  2014-11-12       Impact factor: 25.071

5.  Community-Acquired Pneumonia in HIV-Infected Individuals.

Authors:  James Brown; Marc Lipman
Journal:  Curr Infect Dis Rep       Date:  2014-03       Impact factor: 3.725

6.  Pneumocystis Jirovecii Pneumonia in a Kidney Transplant Recipient 13 Months after Transplantation: A Case Report and Literature Review.

Authors:  Dominykas Varnas; Augustina Jankauskienė
Journal:  Acta Med Litu       Date:  2021-01-25

7.  Incidence of Pneumonia and Predictors Among Human Immunodeficiency Virus Infected Children at Public Health Institutions in the Northwest Part of Ethiopia: Multicenter Retrospective Follow-Up Study.

Authors:  Teshale Mengesha; Tsegasew Embiale; Molla Azmeraw; Gashaw Kerebeh; Sileshi Mulatu; Fentahun Meseret; Minyichil Birhanu
Journal:  Pediatric Health Med Ther       Date:  2022-02-11

8.  Chronic lung disease in HIV-infected children established on antiretroviral therapy.

Authors:  Jamie Rylance; Grace Mchugh; John Metcalfe; Hilda Mujuru; Kusum Nathoo; Stephanie Wilmore; Sarah Rowland-Jones; Edith Majonga; Katharina Kranzer; Rashida A Ferrand
Journal:  AIDS       Date:  2016-11-28       Impact factor: 4.177

9.  Determinants of Under-Five Pneumonia at Gondar University Hospital, Northwest Ethiopia: An Unmatched Case-Control Study.

Authors:  Yordanos Markos; Abel Fekadu Dadi; Abayneh Girma Demisse; Yohannes Ayanaw Habitu; Behailu Tariku Derseh; Getu Debalkie
Journal:  J Environ Public Health       Date:  2019-09-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.